OTC Markets EXMKT - Delayed Quote USD

MusclePharm Corporation (MSLPQ)

Compare
0.0000 0.0000 (0.00%)
At close: October 25 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Ryan Charles Drexler Executive Chairman & CEO 1.64M -- 1971
John Mills Senior Managing Director -- -- --
Mr. Eric Chin Chief Accounting Officer & Director -- -- 1980
Dr. Roscoe M. Moore Jr., DSc, DVM, MPH, Ph.D. Chief Scientific Director & Member of Scientific Advisory Board -- -- 1945

MusclePharm Corporation

6728 West Sunset Road
Suite 130
Las Vegas, NV 89119
United States
800 859 3010 https://www.musclepharm.com
Industry:?
Packaged Foods
Full Time Employees:?
21

Description

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada. On December 15, 2022, MusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Nevada.

Corporate Governance

MusclePharm Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

August 31, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 19, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 10, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 11, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 9, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 21, 2022 at 12:00 AM UTC

SC 13D/A: Tender Offer/Acquisition Reports

September 29, 2022 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 19, 2022 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 23, 2022 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 22, 2022 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters